Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 125 Pages
Report ld: 2711130
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Colloids (Blood Plasma) Market Size(US$)
CAGR 2024-2030
-2.5%
Market Size,2030
USD 339.9
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 395.7 million
Market Forecast in 2030(Value)
US$ 339.9 million
CAGR
-2.5%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
The global Colloids (Blood Plasma) market is projected to grow from US$ 395.7 million in 2024 to US$ 339.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of -2.5% during the forecast period.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Covers:
This report presents an overview of global market for Colloids (Blood Plasma), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Colloids (Blood Plasma), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Colloids (Blood Plasma), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Colloids (Blood Plasma) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Colloids (Blood Plasma) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Colloids (Blood Plasma) sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Kedrion
- Shanghai Raas
- CTBB
- Hualan Bio
- Rongsheng Pharmaceutical
- Boya Rongsheng
- B. Braun Medical
- Fresenius Kabi
- HOSPIRA
- Axa parenterals
- Fresenius Kabi (China)
- CR Double-Crane
- Kelun Group
- Shandong Qidu Pharmaceutical
- Shandong Hualu Pharmaceutical
- Minsheng Pharma
- Kanglepharm
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Type Colloids (Blood Plasma)
- Synthetic Type Colloids (Blood Plasma)
Segment by Application
- Extensive Burns
- Massive Blood or Plasma Loss
- Hypovolemic Shock
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Colloids (Blood Plasma) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colloids (Blood Plasma) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Colloids (Blood Plasma) Product Introduction
1.2 Market by Type
1.2.1 Global Colloids (Blood Plasma) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Market by Application
1.3.1 Global Colloids (Blood Plasma) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Colloids (Blood Plasma) Sales Estimates and Forecasts 2019-2030
2.2 Global Colloids (Blood Plasma) Revenue by Region
2.2.1 Global Colloids (Blood Plasma) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Colloids (Blood Plasma) Revenue by Region (2019-2024)
2.2.3 Global Colloids (Blood Plasma) Revenue by Region (2025-2030)
2.2.4 Global Colloids (Blood Plasma) Revenue Market Share by Region (2019-2030)
2.3 Global Colloids (Blood Plasma) Sales Estimates and Forecasts 2019-2030
2.4 Global Colloids (Blood Plasma) Sales by Region
2.4.1 Global Colloids (Blood Plasma) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Colloids (Blood Plasma) Sales by Region (2019-2024)
2.4.3 Global Colloids (Blood Plasma) Sales by Region (2025-2030)
2.4.4 Global Colloids (Blood Plasma) Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Colloids (Blood Plasma) Sales by Manufacturers
3.1.1 Global Colloids (Blood Plasma) Sales by Manufacturers (2019-2024)
3.1.2 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Colloids (Blood Plasma) in 2023
3.2 Global Colloids (Blood Plasma) Revenue by Manufacturers
3.2.1 Global Colloids (Blood Plasma) Revenue by Manufacturers (2019-2024)
3.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Colloids (Blood Plasma) Revenue in 2023
3.3 Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Colloids (Blood Plasma) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Colloids (Blood Plasma), Product Offered and Application
3.8 Global Key Manufacturers of Colloids (Blood Plasma), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Colloids (Blood Plasma) Sales by Type
4.1.1 Global Colloids (Blood Plasma) Historical Sales by Type (2019-2024)
4.1.2 Global Colloids (Blood Plasma) Forecasted Sales by Type (2025-2030)
4.1.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
4.2 Global Colloids (Blood Plasma) Revenue by Type
4.2.1 Global Colloids (Blood Plasma) Historical Revenue by Type (2019-2024)
4.2.2 Global Colloids (Blood Plasma) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
4.3 Global Colloids (Blood Plasma) Price by Type
4.3.1 Global Colloids (Blood Plasma) Price by Type (2019-2024)
4.3.2 Global Colloids (Blood Plasma) Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Colloids (Blood Plasma) Sales by Application
5.1.1 Global Colloids (Blood Plasma) Historical Sales by Application (2019-2024)
5.1.2 Global Colloids (Blood Plasma) Forecasted Sales by Application (2025-2030)
5.1.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
5.2 Global Colloids (Blood Plasma) Revenue by Application
5.2.1 Global Colloids (Blood Plasma) Historical Revenue by Application (2019-2024)
5.2.2 Global Colloids (Blood Plasma) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
5.3 Global Colloids (Blood Plasma) Price by Application
5.3.1 Global Colloids (Blood Plasma) Price by Application (2019-2024)
5.3.2 Global Colloids (Blood Plasma) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Colloids (Blood Plasma) Market Size by Type
6.1.1 US & Canada Colloids (Blood Plasma) Sales by Type (2019-2030)
6.1.2 US & Canada Colloids (Blood Plasma) Revenue by Type (2019-2030)
6.2 US & Canada Colloids (Blood Plasma) Market Size by Application
6.2.1 US & Canada Colloids (Blood Plasma) Sales by Application (2019-2030)
6.2.2 US & Canada Colloids (Blood Plasma) Revenue by Application (2019-2030)
6.3 US & Canada Colloids (Blood Plasma) Market Size by Country
6.3.1 US & Canada Colloids (Blood Plasma) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Colloids (Blood Plasma) Sales by Country (2019-2030)
6.3.3 US & Canada Colloids (Blood Plasma) Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Colloids (Blood Plasma) Market Size by Type
7.1.1 Europe Colloids (Blood Plasma) Sales by Type (2019-2030)
7.1.2 Europe Colloids (Blood Plasma) Revenue by Type (2019-2030)
7.2 Europe Colloids (Blood Plasma) Market Size by Application
7.2.1 Europe Colloids (Blood Plasma) Sales by Application (2019-2030)
7.2.2 Europe Colloids (Blood Plasma) Revenue by Application (2019-2030)
7.3 Europe Colloids (Blood Plasma) Market Size by Country
7.3.1 Europe Colloids (Blood Plasma) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Colloids (Blood Plasma) Sales by Country (2019-2030)
7.3.3 Europe Colloids (Blood Plasma) Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Colloids (Blood Plasma) Market Size
8.1.1 China Colloids (Blood Plasma) Sales (2019-2030)
8.1.2 China Colloids (Blood Plasma) Revenue (2019-2030)
8.2 China Colloids (Blood Plasma) Market Size by Application
8.2.1 China Colloids (Blood Plasma) Sales by Application (2019-2030)
8.2.2 China Colloids (Blood Plasma) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Colloids (Blood Plasma) Market Size by Type
9.1.1 Asia Colloids (Blood Plasma) Sales by Type (2019-2030)
9.1.2 Asia Colloids (Blood Plasma) Revenue by Type (2019-2030)
9.2 Asia Colloids (Blood Plasma) Market Size by Application
9.2.1 Asia Colloids (Blood Plasma) Sales by Application (2019-2030)
9.2.2 Asia Colloids (Blood Plasma) Revenue by Application (2019-2030)
9.3 Asia Colloids (Blood Plasma) Sales by Region
9.3.1 Asia Colloids (Blood Plasma) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Colloids (Blood Plasma) Revenue by Region (2019-2030)
9.3.3 Asia Colloids (Blood Plasma) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Colloids (Blood Plasma) Market Size by Type
10.1.1 Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Colloids (Blood Plasma) Market Size by Application
10.2.1 Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Country
10.3.1 Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 CSL Behring Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Overview
11.2.3 Baxter Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Baxter Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Grifols Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Kedrion Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 Shanghai Raas
11.6.1 Shanghai Raas Company Information
11.6.2 Shanghai Raas Overview
11.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Shanghai Raas Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai Raas Recent Developments
11.7 CTBB
11.7.1 CTBB Company Information
11.7.2 CTBB Overview
11.7.3 CTBB Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 CTBB Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CTBB Recent Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Company Information
11.8.2 Hualan Bio Overview
11.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Hualan Bio Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hualan Bio Recent Developments
11.9 Rongsheng Pharmaceutical
11.9.1 Rongsheng Pharmaceutical Company Information
11.9.2 Rongsheng Pharmaceutical Overview
11.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Rongsheng Pharmaceutical Recent Developments
11.10 Boya Rongsheng
11.10.1 Boya Rongsheng Company Information
11.10.2 Boya Rongsheng Overview
11.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Boya Rongsheng Recent Developments
11.11 B. Braun Medical
11.11.1 B. Braun Medical Company Information
11.11.2 B. Braun Medical Overview
11.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 B. Braun Medical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 B. Braun Medical Recent Developments
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Information
11.12.2 Fresenius Kabi Overview
11.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Fresenius Kabi Recent Developments
11.13 HOSPIRA
11.13.1 HOSPIRA Company Information
11.13.2 HOSPIRA Overview
11.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 HOSPIRA Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 HOSPIRA Recent Developments
11.14 Axa parenterals
11.14.1 Axa parenterals Company Information
11.14.2 Axa parenterals Overview
11.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Axa parenterals Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Axa parenterals Recent Developments
11.15 Fresenius Kabi (China)
11.15.1 Fresenius Kabi (China) Company Information
11.15.2 Fresenius Kabi (China) Overview
11.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Fresenius Kabi (China) Recent Developments
11.16 CR Double-Crane
11.16.1 CR Double-Crane Company Information
11.16.2 CR Double-Crane Overview
11.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 CR Double-Crane Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CR Double-Crane Recent Developments
11.17 Kelun Group
11.17.1 Kelun Group Company Information
11.17.2 Kelun Group Overview
11.17.3 Kelun Group Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Kelun Group Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Kelun Group Recent Developments
11.18 Shandong Qidu Pharmaceutical
11.18.1 Shandong Qidu Pharmaceutical Company Information
11.18.2 Shandong Qidu Pharmaceutical Overview
11.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Shandong Qidu Pharmaceutical Recent Developments
11.19 Shandong Hualu Pharmaceutical
11.19.1 Shandong Hualu Pharmaceutical Company Information
11.19.2 Shandong Hualu Pharmaceutical Overview
11.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Shandong Hualu Pharmaceutical Recent Developments
11.20 Minsheng Pharma
11.20.1 Minsheng Pharma Company Information
11.20.2 Minsheng Pharma Overview
11.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Minsheng Pharma Recent Developments
11.21 Kanglepharm
11.21.1 Kanglepharm Company Information
11.21.2 Kanglepharm Overview
11.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Kanglepharm Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Kanglepharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Colloids (Blood Plasma) Industry Chain Analysis
12.2 Colloids (Blood Plasma) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Colloids (Blood Plasma) Production Mode & Process
12.4 Colloids (Blood Plasma) Sales and Marketing
12.4.1 Colloids (Blood Plasma) Sales Channels
12.4.2 Colloids (Blood Plasma) Distributors
12.5 Colloids (Blood Plasma) Customers
13 Market Dynamics
13.1 Colloids (Blood Plasma) Industry Trends
13.2 Colloids (Blood Plasma) Market Drivers
13.3 Colloids (Blood Plasma) Market Challenges
13.4 Colloids (Blood Plasma) Market Restraints
14 Key Findings in The Global Colloids (Blood Plasma) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Colloids (Blood Plasma) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Natural Type Colloids (Blood Plasma)
Table 3. Major Manufacturers of Synthetic Type Colloids (Blood Plasma)
Table 4. Global Colloids (Blood Plasma) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Colloids (Blood Plasma) Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Colloids (Blood Plasma) Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Colloids (Blood Plasma) Revenue Market Share by Region (2019-2024)
Table 9. Global Colloids (Blood Plasma) Revenue Market Share by Region (2025-2030)
Table 10. Global Colloids (Blood Plasma) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Colloids (Blood Plasma) Sales by Region (2019-2024) & (MT)
Table 12. Global Colloids (Blood Plasma) Sales by Region (2025-2030) & (MT)
Table 13. Global Colloids (Blood Plasma) Sales Market Share by Region (2019-2024)
Table 14. Global Colloids (Blood Plasma) Sales Market Share by Region (2025-2030)
Table 15. Global Colloids (Blood Plasma) Sales by Manufacturers (2019-2024) & (MT)
Table 16. Global Colloids (Blood Plasma) Sales Share by Manufacturers (2019-2024)
Table 17. Global Colloids (Blood Plasma) Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Colloids (Blood Plasma), Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Colloids (Blood Plasma) Price by Manufacturers 2019-2024 (USD/Kg)
Table 21. Global Colloids (Blood Plasma) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2023)
Table 23. Global Key Manufacturers of Colloids (Blood Plasma), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Colloids (Blood Plasma), Product Offered and Application
Table 25. Global Key Manufacturers of Colloids (Blood Plasma), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Colloids (Blood Plasma) Sales by Type (2019-2024) & (MT)
Table 28. Global Colloids (Blood Plasma) Sales by Type (2025-2030) & (MT)
Table 29. Global Colloids (Blood Plasma) Sales Share by Type (2019-2024)
Table 30. Global Colloids (Blood Plasma) Sales Share by Type (2025-2030)
Table 31. Global Colloids (Blood Plasma) Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Colloids (Blood Plasma) Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Colloids (Blood Plasma) Revenue Share by Type (2019-2024)
Table 34. Global Colloids (Blood Plasma) Revenue Share by Type (2025-2030)
Table 35. Colloids (Blood Plasma) Price by Type (2019-2024) & (USD/Kg)
Table 36. Global Colloids (Blood Plasma) Price Forecast by Type (2025-2030) & (USD/Kg)
Table 37. Global Colloids (Blood Plasma) Sales by Application (2019-2024) & (MT)
Table 38. Global Colloids (Blood Plasma) Sales by Application (2025-2030) & (MT)
Table 39. Global Colloids (Blood Plasma) Sales Share by Application (2019-2024)
Table 40. Global Colloids (Blood Plasma) Sales Share by Application (2025-2030)
Table 41. Global Colloids (Blood Plasma) Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Colloids (Blood Plasma) Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Colloids (Blood Plasma) Revenue Share by Application (2019-2024)
Table 44. Global Colloids (Blood Plasma) Revenue Share by Application (2025-2030)
Table 45. Colloids (Blood Plasma) Price by Application (2019-2024) & (USD/Kg)
Table 46. Global Colloids (Blood Plasma) Price Forecast by Application (2025-2030) & (USD/Kg)
Table 47. US & Canada Colloids (Blood Plasma) Sales by Type (2019-2024) & (MT)
Table 48. US & Canada Colloids (Blood Plasma) Sales by Type (2025-2030) & (MT)
Table 49. US & Canada Colloids (Blood Plasma) Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Colloids (Blood Plasma) Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Colloids (Blood Plasma) Sales by Application (2019-2024) & (MT)
Table 52. US & Canada Colloids (Blood Plasma) Sales by Application (2025-2030) & (MT)
Table 53. US & Canada Colloids (Blood Plasma) Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Colloids (Blood Plasma) Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Colloids (Blood Plasma) Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Colloids (Blood Plasma) Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Colloids (Blood Plasma) Sales by Country (2019-2024) & (MT)
Table 59. US & Canada Colloids (Blood Plasma) Sales by Country (2025-2030) & (MT)
Table 60. Europe Colloids (Blood Plasma) Sales by Type (2019-2024) & (MT)
Table 61. Europe Colloids (Blood Plasma) Sales by Type (2025-2030) & (MT)
Table 62. Europe Colloids (Blood Plasma) Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Colloids (Blood Plasma) Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Colloids (Blood Plasma) Sales by Application (2019-2024) & (MT)
Table 65. Europe Colloids (Blood Plasma) Sales by Application (2025-2030) & (MT)
Table 66. Europe Colloids (Blood Plasma) Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Colloids (Blood Plasma) Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Colloids (Blood Plasma) Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Colloids (Blood Plasma) Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Colloids (Blood Plasma) Sales by Country (2019-2024) & (MT)
Table 72. Europe Colloids (Blood Plasma) Sales by Country (2025-2030) & (MT)
Table 73. China Colloids (Blood Plasma) Sales by Type (2019-2024) & (MT)
Table 74. China Colloids (Blood Plasma) Sales by Type (2025-2030) & (MT)
Table 75. China Colloids (Blood Plasma) Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Colloids (Blood Plasma) Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Colloids (Blood Plasma) Sales by Application (2019-2024) & (MT)
Table 78. China Colloids (Blood Plasma) Sales by Application (2025-2030) & (MT)
Table 79. China Colloids (Blood Plasma) Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Colloids (Blood Plasma) Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Colloids (Blood Plasma) Sales by Type (2019-2024) & (MT)
Table 82. Asia Colloids (Blood Plasma) Sales by Type (2025-2030) & (MT)
Table 83. Asia Colloids (Blood Plasma) Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Colloids (Blood Plasma) Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Colloids (Blood Plasma) Sales by Application (2019-2024) & (MT)
Table 86. Asia Colloids (Blood Plasma) Sales by Application (2025-2030) & (MT)
Table 87. Asia Colloids (Blood Plasma) Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Colloids (Blood Plasma) Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Colloids (Blood Plasma) Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Colloids (Blood Plasma) Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Colloids (Blood Plasma) Sales by Region (2019-2024) & (MT)
Table 93. Asia Colloids (Blood Plasma) Sales by Region (2025-2030) & (MT)
Table 94. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Type (2019-2024) & (MT)
Table 95. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Type (2025-2030) & (MT)
Table 96. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Application (2019-2024) & (MT)
Table 99. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Application (2025-2030) & (MT)
Table 100. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Country (2019-2024) & (MT)
Table 106. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales by Country (2025-2030) & (MT)
Table 107. CSL Behring Company Information
Table 108. CSL Behring Description and Major Businesses
Table 109. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 110. CSL Behring Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Behring Recent Developments
Table 112. Baxter Company Information
Table 113. Baxter Description and Major Businesses
Table 114. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 115. Baxter Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Baxter Recent Developments
Table 117. Grifols Company Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 120. Grifols Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. Octapharma Company Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 125. Octapharma Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Kedrion Company Information
Table 128. Kedrion Description and Major Businesses
Table 129. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 130. Kedrion Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Kedrion Recent Developments
Table 132. Shanghai Raas Company Information
Table 133. Shanghai Raas Description and Major Businesses
Table 134. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 135. Shanghai Raas Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Shanghai Raas Recent Developments
Table 137. CTBB Company Information
Table 138. CTBB Description and Major Businesses
Table 139. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 140. CTBB Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. CTBB Recent Developments
Table 142. Hualan Bio Company Information
Table 143. Hualan Bio Description and Major Businesses
Table 144. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 145. Hualan Bio Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hualan Bio Recent Developments
Table 147. Rongsheng Pharmaceutical Company Information
Table 148. Rongsheng Pharmaceutical Description and Major Businesses
Table 149. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 150. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Rongsheng Pharmaceutical Recent Developments
Table 152. Boya Rongsheng Company Information
Table 153. Boya Rongsheng Description and Major Businesses
Table 154. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 155. Boya Rongsheng Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Boya Rongsheng Recent Developments
Table 157. B. Braun Medical Company Information
Table 158. B. Braun Medical Description and Major Businesses
Table 159. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 160. B. Braun Medical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. B. Braun Medical Recent Developments
Table 162. Fresenius Kabi Company Information
Table 163. Fresenius Kabi Description and Major Businesses
Table 164. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 165. Fresenius Kabi Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Fresenius Kabi Recent Developments
Table 167. HOSPIRA Company Information
Table 168. HOSPIRA Description and Major Businesses
Table 169. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 170. HOSPIRA Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. HOSPIRA Recent Developments
Table 172. Axa parenterals Company Information
Table 173. Axa parenterals Description and Major Businesses
Table 174. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 175. Axa parenterals Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Axa parenterals Recent Developments
Table 177. Fresenius Kabi (China) Company Information
Table 178. Fresenius Kabi (China) Description and Major Businesses
Table 179. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 180. Fresenius Kabi (China) Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Fresenius Kabi (China) Recent Developments
Table 182. CR Double-Crane Company Information
Table 183. CR Double-Crane Description and Major Businesses
Table 184. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 185. CR Double-Crane Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. CR Double-Crane Recent Developments
Table 187. Kelun Group Company Information
Table 188. Kelun Group Description and Major Businesses
Table 189. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 190. Kelun Group Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Kelun Group Recent Developments
Table 192. Shandong Qidu Pharmaceutical Company Information
Table 193. Shandong Qidu Pharmaceutical Description and Major Businesses
Table 194. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 195. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Shandong Qidu Pharmaceutical Recent Developments
Table 197. Shandong Hualu Pharmaceutical Company Information
Table 198. Shandong Hualu Pharmaceutical Description and Major Businesses
Table 199. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 200. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Shandong Hualu Pharmaceutical Recent Developments
Table 202. Minsheng Pharma Company Information
Table 203. Minsheng Pharma Description and Major Businesses
Table 204. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 205. Minsheng Pharma Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Minsheng Pharma Recent Developments
Table 207. Kanglepharm Company Information
Table 208. Kanglepharm Description and Major Businesses
Table 209. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 210. Kanglepharm Colloids (Blood Plasma) Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Kanglepharm Recent Developments
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Colloids (Blood Plasma) Distributors List
Table 215. Colloids (Blood Plasma) Customers List
Table 216. Colloids (Blood Plasma) Market Trends
Table 217. Colloids (Blood Plasma) Market Drivers
Table 218. Colloids (Blood Plasma) Market Challenges
Table 219. Colloids (Blood Plasma) Market Restraints
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Colloids (Blood Plasma) Product Picture
Figure 2. Global Colloids (Blood Plasma) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Colloids (Blood Plasma) Market Share by Type in 2023 & 2030
Figure 4. Natural Type Colloids (Blood Plasma) Product Picture
Figure 5. Synthetic Type Colloids (Blood Plasma) Product Picture
Figure 6. Global Colloids (Blood Plasma) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Colloids (Blood Plasma) Market Share by Application in 2023 & 2030
Figure 8. Extensive Burns
Figure 9. Massive Blood or Plasma Loss
Figure 10. Hypovolemic Shock
Figure 11. Others
Figure 12. Colloids (Blood Plasma) Report Years Considered
Figure 13. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Colloids (Blood Plasma) Revenue 2019-2030 (US$ Million)
Figure 15. Global Colloids (Blood Plasma) Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Colloids (Blood Plasma) Revenue Market Share by Region (2019-2030)
Figure 17. Global Colloids (Blood Plasma) Sales 2019-2030 ((MT)
Figure 18. Global Colloids (Blood Plasma) Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Colloids (Blood Plasma) Sales YoY (2019-2030) & (MT)
Figure 20. US & Canada Colloids (Blood Plasma) Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Colloids (Blood Plasma) Sales YoY (2019-2030) & (MT)
Figure 22. Europe Colloids (Blood Plasma) Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Colloids (Blood Plasma) Sales YoY (2019-2030) & (MT)
Figure 24. China Colloids (Blood Plasma) Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Colloids (Blood Plasma) Sales YoY (2019-2030) & (MT)
Figure 26. Asia (excluding China) Colloids (Blood Plasma) Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales YoY (2019-2030) & (MT)
Figure 28. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Colloids (Blood Plasma) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Colloids (Blood Plasma) in the World: Market Share by Colloids (Blood Plasma) Revenue in 2023
Figure 31. Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
Figure 33. Global Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
Figure 34. Global Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
Figure 35. Global Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Colloids (Blood Plasma) Revenue Share by Country (2019-2030)
Figure 41. US & Canada Colloids (Blood Plasma) Sales Share by Country (2019-2030)
Figure 42. U.S. Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
Figure 45. Europe Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
Figure 46. Europe Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
Figure 47. Europe Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
Figure 48. Europe Colloids (Blood Plasma) Revenue Share by Country (2019-2030)
Figure 49. Europe Colloids (Blood Plasma) Sales Share by Country (2019-2030)
Figure 50. Germany Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 51. France Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 55. China Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
Figure 56. China Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
Figure 57. China Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
Figure 58. China Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
Figure 59. Asia Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
Figure 60. Asia Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
Figure 61. Asia Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
Figure 62. Asia Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
Figure 63. Asia Colloids (Blood Plasma) Revenue Share by Region (2019-2030)
Figure 64. Asia Colloids (Blood Plasma) Sales Share by Region (2019-2030)
Figure 65. Japan Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 69. India Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Colloids (Blood Plasma) Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Colloids (Blood Plasma) Sales Share by Country (2019-2030)
Figure 76. Brazil Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Colloids (Blood Plasma) Revenue (2019-2030) & (US$ Million)
Figure 81. Colloids (Blood Plasma) Value Chain
Figure 82. Colloids (Blood Plasma) Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Colloids (Blood Plasma) market?
The top companies in the global Colloids (Blood Plasma) market are CSL Behring、Baxter、Grifols.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Colloids (Blood Plasma) market size from 2024 to 2030?
What was the global market size of Colloids (Blood Plasma) in 2030?
What was the global market size of Colloids (Blood Plasma) in 2024?
Related Reports
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 114
USD 4250.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 143
USD 2900.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 167
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 189
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 196
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 157
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)
Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-17
Pages: 202
USD 5600.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-16
Pages: 192
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 114
USD 4250.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 143
USD 2900.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 167
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 189
USD 4900.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 196
USD 5900.00 (Single User License)Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 157
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-17
Pages: 202
USD 5600.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-16
Pages: 192
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now